Sawaf Aziz 4
4 · Theravance Biopharma, Inc. · Filed Apr 4, 2024
Insider Transaction Report
Form 4
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
Transactions
- Award
Ordinary Shares
2024-04-02+100,000→ 338,636 total
Footnotes (1)
- [F1]On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.